Kaneka’s ubiquinol supplement helps French nurses fight fatigue during pandemic, trial finds

A survey and trial conducted by French healthcare market research company Expansion Consulteam found that nurses working during the COVID-19 pandemic who took a ubiquinol supplement daily felt less tired and stressed.

A survey and trial conducted by French healthcare market research company Expansion Consulteam found that nurses working during the COVID-19 pandemic who took a ubiquinol supplement daily felt less tired and stressed.

During the pandemic, 85 unvaccinated French nurses were asked to supplement with 100 mg daily of ubiquinol for 60 days. The supplement contained Ubiquinol, a trademarked ubiquinol ingredient from supplier Kaneka Nutrients Europe (Zaventem, Belgium). Ubiquinol is the active form of coenzyme Q10 that supports the body’s own natural supply and helps cells produce energy.

Half of the supplemented nurses worked in hospitals, and half worked in private practice. Prior to the trial, most participants reported experiencing “stress, tiredness, and mental exhaustion.” At the end of the 60 days of supplementation, 62% of participants reported feeling less stressed, 55% said they felt less physically fatigued, and 56% said they felt less mentally fatigued, compared to before supplementation started. Improvements on average were reported to occur 24 days after the trial’s start.

The news was reported by Kaneka. In a Kaneka press release, Filip Van hulle, general manager, Kaneka Nutrients Europe, stated, “Many consumers are currently looking to improve their overall health, and ubiquinol could well be the solution. It supports several areas simultaneously, such as heart health, immunity, and mental well-being, and contributes to improved energy and endurance.”